HMGB1 and neoplasm: The combination of HMGB1 with Toll-like receptors and RAGE leads to the activation of nuclear factor-κB (NF-κB) (33) and concurrently increases angiogenic factor production, tumor tissue destruction, and further promotes the inflammatory response (34).